Found 7 matching trials
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
PHASE3RATIONALE: Vaccines made from a peptide may help the body build an effectiv...
Location
Mayo Clinic Scottsdale
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
PHASE1This study will test whether certain patients with myelodysplastic syndrome...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers
PHASE2This study will test the safety and effectiveness of two vaccines on slowin...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
PHASE1Vaccines made from peptides that are found on leukemia cells may make the b...
Location
M D Anderson Cancer Center
PR1 Vaccination in Myelodysplastic Syndrome (MDS)
PHASE2Primary aim:
1. To determine the immunologic response, using a PR1-HLA-A2 ...
Location
U.T. M.D. Anderson Cancer Center
Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)
PHASE2The goal of this clinical research study is to find out if using the PR1 pe...
Location
UT MD . Anderson Cancer Center
Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
PHASE2RATIONALE: Vaccines made from peptides may help the body build an effective...
Location
M. D. Anderson Cancer Center at University of Texas